Use access key #2 to skip to page content.
$3.44 0.14 (4.24%)
12/3/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

3

Avatar TDL5150 (80.63) Submitted: 7/09/08 4:57 AM : Outperform Start Price: $5.33 EXEL Score: -3.95

Another MDP recommendation who has taken a beating in recent weeks. That being said - they have a good pipeline and feel it is a great time to buy

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links